Literature DB >> 18362217

The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation.

Mehdi Hamadani, Farrukh T Awan, Steven M Devine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18362217     DOI： 10.1182/blood-2008-01-132050

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  16 in total

1.  Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.

Authors:  Bradley W Blaser; Haesook T Kim; Edwin P Alyea; Vincent T Ho; Corey Cutler; Philippe Armand; John Koreth; Joseph H Antin; Jorge Plutzky; Robert J Soiffer
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-11       Impact factor: 5.742

Review 2.  Regulation of different inflammatory diseases by impacting the mevalonate pathway.

Authors:  Robert Zeiser; Kristina Maas; Sawsan Youssef; Christoph Dürr; Lawrence Steinman; Robert S Negrin
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 3.  Current and emerging strategies for the prevention of graft-versus-host disease.

Authors:  Sung Won Choi; Pavan Reddy
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

4.  The evolving role of statins in hematopoietic stem and progenitor cell transplantation.

Authors:  Mehdi Hamadani; Michael D Craig; Laura F Gibson; Scot C Remick
Journal:  Am J Blood Res       Date:  2011-06-01

5.  Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Marcello Rotta; Barry E Storer; Rainer Storb; Paul J Martin; Mary E D Flowers; Miwa S Vernon; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-26       Impact factor: 5.742

Review 6.  Immune modulatory effects of statins.

Authors:  Robert Zeiser
Journal:  Immunology       Date:  2018-02-20       Impact factor: 7.397

Review 7.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

8.  Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.

Authors:  Marcello Rotta; Barry E Storer; Rainer F Storb; Paul J Martin; Shelly Heimfeld; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Journal:  Blood       Date:  2009-12-04       Impact factor: 22.113

9.  Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).

Authors:  Yvonne A Efebera; Susan Geyer; Leslie Andritsos; Sumithira Vasu; Samantha Jaglowski; Anissa Bingman; William Blum; Rebecca Klisovic; Craig C Hofmeister; Don M Benson; Sam Penza; Patrick Elder; Katie Cortright; Rhonda Kitzler; Kevin Coombes; Lynn O'Donnell; Beth Daneault; Hillary Bradbury; Jianying Zhang; Xilin Chen; Sabrina Garman; Parvathi Ranganathan; Xueyan Yu; Jessica Hofstetter; Jianhua Yu; Ramiro Garzon; Scott R Scrape; Gerard Lozanski; Steven M Devine
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-06       Impact factor: 5.742

10.  Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation.

Authors:  Erin Gatza; Sung Won Choi
Journal:  Int J Hematol Oncol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.